# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001171843-19-001915
Filing Date
2019-03-22
Accepted
2019-03-22 16:01:40
Documents
58
Period of Report
2018-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-K | f10k_032219.htm | 10-K | 670777
2 | EXHIBIT 31.1 | exh_311.htm | EX-31.1 | 6988
3 | EXHIBIT 31.2 | exh_312.htm | EX-31.2 | 7038
4 | EXHIBIT 32.1 | exh_321.htm | EX-32.1 | 3699
| Complete submission text file | 0001171843-19-001915.txt |  | 4524484

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL INSTANCE FILE | caps-20181231.xml | EX-101.INS | 979084
6 | XBRL SCHEMA FILE | caps-20181231.xsd | EX-101.SCH | 37475
7 | XBRL CALCULATION FILE | caps-20181231_cal.xml | EX-101.CAL | 28159
8 | XBRL DEFINITION FILE | caps-20181231_def.xml | EX-101.DEF | 245165
9 | XBRL LABEL FILE | caps-20181231_lab.xml | EX-101.LAB | 272561
10 | XBRL PRESENTATION FILE | caps-20181231_pre.xml | EX-101.PRE | 291837

Mailing Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281
Business Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281 6022865520
Capstone Therapeutics Corp. (Filer) CIK: 0000887151 (see all company filings)

EIN.: 860585310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21214 | Film No.: 19699800
SIC: 2834 Pharmaceutical Preparations